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Abstract
Activation of the mammalian Notch receptor after ligand binding relies on a succession of events including
metalloprotease-cleavage, endocytosis, monoubiquitination, and eventually processing by the gamma-secretase, giving
rise to a soluble, transcriptionally active molecule. The Notch1 receptor was proposed to be monoubiquitinated before its
gamma-secretase cleavage; the targeted lysine has been localized to its submembrane domain. Investigating how this step
might be regulated by a deubiquitinase (DUB) activity will provide new insight for understanding Notch receptor activation
and downstream signaling. An immunofluorescence-based screening of an shRNA library allowed us to identify eIF3f,
previously known as one of the subunits of the translation initiation factor eIF3, as a DUB targeting the activated Notch
receptor. We show that eIF3f has an intrinsic DUB activity. Knocking down eIF3f leads to an accumulation of
monoubiquitinated forms of activated Notch, an effect counteracted by murine WT eIF3f but not by a catalytically inactive
mutant. We also show that eIF3f is recruited to activated Notch on endocytic vesicles by the putative E3 ubiquitin ligase
Deltex1, which serves as a bridging factor. Finally, catalytically inactive forms of eIF3f as well as shRNAs targeting eIF3f
repress Notch activation in a coculture assay, showing that eIF3f is a new positive regulator of the Notch pathway. Our
results support two new and provocative conclusions: (1) The activated form of Notch needs to be deubiquitinated before
being processed by the gamma-secretase activity and entering the nucleus, where it fulfills its transcriptional function. (2)
The enzyme accounting for this deubiquitinase activity is eIF3f, known so far as a translation initiation factor. These data
improve our knowledge of Notch signaling but also open new avenues of research on the Zomes family and the translation
initiation factors.
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Introduction
Notch signaling relies on two consecutive cleavages of the
receptor after binding of its ligand expressed by a neighboring cell.
These two processing steps successively performed by a protease of
the ADAM family and by the c-secretase complex can occur only
if the activated receptors on one side, the ligands on the other side,
undergo post-translational modifications and trafficking. Some of
these complex events begin to be elucidated [1–7]. They
essentially depend on ubiquitination events affecting the ligand
and/or the receptor, and probably regulating sorting and
trafficking of the activated versus non-activated molecules.
Eventually, after proteolytic release the intracellular portion of
Notch (hereafter named NIC) enters the nucleus, where it
functions as a transcriptional co-activator of Notch target genes.
In mammals, the Notch1 receptor was proposed to be
monoubiquitinated before its c-secretase cleavage; the targeted
lysine has been localized to its submembrane domain [8].
Investigating how this monoubiquitination is regulated may be
crucial for understanding Notch receptor activation and down-
stream signaling. Ubiquitination is a reversible process, and
deubiquitinating enzymes (DUBs) remove the ubiquitin moieties
from ubiquitinated substrates, thus allowing a tight control of these
modifications [9]. A potential deubiquitination step could either
affect NIC production by c-secretase, NIC release from the
endocytic vesicles, NIC entry into the nucleus, NIC interaction
with its transcriptional cofactors, NIC transcriptional activity, or
NIC stability. With the aim of identifying a DUB involved in Notch
signaling, we established a screening strategy using shRNA vectors
targeting the putative and known DUBs of the human genome[10].
Here, we report the identification of eIF3f as a DUB targeting the
activated Notch receptor and positively regulating Notch signaling.
eIF3f (for eukaryotic translation initiation factor 3 subunit f) is
one of the 13 subunits (named eIF3a-m) of the translation
PLoS Biology | www.plosbiology.org 1 November 2010 | Volume 8 | Issue 11 | e1000545initiation factor eIF3. eIF3 stimulates many steps of the translation
initiation pathway, including assembly of the eIF2-GTP/met-
tRNA complex to the 40S ribosome to form the 43S preinitiation
complex (PIC), mRNA recruitment to the 43S PIC complex,
impairment of the 40S ribosome to join the 60S prematurely, and
scanning the mRNA for AUG recognition [11]. eIF3 has no
known enzymatic activity so far, but it has an intriguing degree of
homology with two other complexes whose functions appear
unrelated: the COP9 signalosome and the 19S proteasome lid. All
three complexes, forming the Zomes family, consist of subunits
with either PCI (Proteasome-COP9 signalosome-initiation factor 3
domain) or MPN (for MPR1-PAD1-N-terminal domain) signature
domains and share a common 6PCI +2 MPN domain stoechio-
metry. The mammalian eIF3 also has an additional five non-PCI-
MPN subunits [12]. The MPN domain of CSN5 (COP9
Signalosome subunit 5) harbors a metalloprotease motif referred
to as the Jab/MPN domain-associated metallopeptidase (JAMM)
motif and regulates the activity of E3 ubiquitin ligases by
deneddylation of the cullin component. On the other hand, a
JAMM-containing subunit associated with the 19S proteasome lid
(Rpn11, [13]) also harbors DUB activity, accounting for substrates
deubiquitination before they enter the proteasome channel.
Interestingly, eIF3f contains a JAMM domain, making it a
putative DUB [14,15]. We show here that it harbors a DUB
activity acting on Notch signaling.
Results
Identification of eIF3f
In order to identify DUBs involved in the Notch signaling
pathway, we set up an immunofluorescence screen. We used
Notch DE [16], a mutant form of Notch deleted of most of its
extracellular domain. DE mimics the ADAM-cleavage product
and therefore represents a constitutively active form, which is
monoubiquitinated and endocytosed [8] before being cleaved by
c-secretase to liberate NIC [17]. We made use of the V1744
antibody to monitor the production and the localization of NIC,
whereas anti-myc antibody detected all Notch products. U2OS
cells were co-transfected with vectors encoding DE and with each
individual pool of a shRNA library targeting the 91 known or
putative DUBs encoded by the human genome (called shDUB
library; see Table 1) [10]. With DE alone (Figure 1A, Panel A), we
observed a membrane and endomembrane-localized myc labeling
corresponding to the unprocessed Notch DE, but also a nuclear
myc labeling (A3) corresponding to NIC, co-stained with the
V1744 antibody (A4). The same pattern was observed with almost
every shRNA pool of the library (exemplified in Panels B1–4),
whereas four pools abolished DE expression (those targeting
eIF3h, PRP8 and USP54, and Pool 2, see below). However, with
an shRNA pool targeting eIF3f (panels C), we observed a partial
extra-nuclear V1744 labeling (C4), as well as an increase in the
average proportion of extranuclear/nuclear myc staining (see
Figure S1, Dose 1). This suggests that NIC production and
localization was affected when eIF3f was knocked down.
The shRNA library actually contained two pools (each
containing four shRNA-encoding plasmids) targeting eIF3f: Pool
1, whose effects are shown in Figure 1A, and Pool 2, in the
presence of which no DE-positive signal could be detected by
immunofluorescence (unpublished data). We isolated the eight
shRNAs from these pools (six different shRNAs in total) and tested
them individually for their efficiency in knocking down eIF3f: Pool
1 (P1) contains shRNA #1t o#4, Pool 2 (P2) contains shRNA #1,
#2, #5, and #6. HEK293T cells were transfected with each of
these shRNAs and the levels of endogenous or overexpressed
human HA-tagged eIF3f were analyzed by Western blotting. Anti-
a-Tubulin was used as a loading control (Figure 1B, bottom panel),
since this protein is very stable and reflects the total protein
content in transfected and non-transfected cells. shRNAs #1 and
#2 significantly affected the level of endogenous and transfected
eIF3f (Figure 1B, Lanes B and C and quantification under the
lanes), similar to the Pool 1 (P1, Lane I). The additional shRNAs
from Pool 2 (#5 and #6 in Lanes J and K) and Pool 2 itself (P2,
Lane L) almost completely abolished eIF3f expression in this assay.
The effect of each of these shRNAs on eIF3f protein level was
correlated with its ability to inhibit DE expression in immunoflu-
orescence experiments and probably reflects eIF3f requirement for
translation (Figure S1). Indeed shRNAs #3 and #4, which
exhibited a minor effect on the expression of the eIF3f protein
(Figure 1B, Lanes D–G), were the most efficient in inducing
extranuclear V1744 labeling in a dose-dependent manner
(Figure 1C). Nevertheless, further increasing the dose of these
two shRNAs separately or co-transfecting them resulted in an
effect on eIF3f expression (Figure 1B, Lanes E, G, and H) and an
extinction of the DE signal in immunofluorescence (Figure S1 and
unpublished data). Since the shRNAs that affect Notch signaling
target different sequences of eI3Ff, and since this effect is
complemented by transfection of wt eIF3f (see below), we can
exclude an off-target effect of these shRNAs. Taken together, these
results suggest that a specific but mild knockdown of eIF3f is
responsible for the altered Notch localization observed in Figure 1.
eIF3f Is Involved in the Deubiquitination of Activated
Notch
We next tested the effect of eIF3f on the ubiquitination of
activated Notch. HEK293T cells were transfected with vectors
encoding DE and a 6xHis-tagged Ubiquitin. We added increasing
amounts of shRNA #3, without reaching the doses used in
Figure 1B, Lane E, in the presence or not of a murine form of
eIF3f (meIF3f). The murine eIF3f cDNA exhibits a three base pair
change in the sequence targeted by shRNA #3 and is therefore
refractory to its effect. Proteins were extracted in denaturing
conditions and ubiquitinated proteins were purified on Nickel-
charged beads. Finally, whole cell extracts and ubiquitinated
products were analyzed by Western blot to quantify the levels of
ubiquitinated Notch (Figure 2A). Transfection of shRNA #3 led
Author Summary
The highly conserved signaling pathway involving the
transmembrane receptor Notch is essential for develop-
ment, and misregulation of this pathway is linked to many
diseases. We previously proposed that the Notch1 receptor
is monoubiquitinated during its activation. With the aim of
identifying a deubiquinating enzyme that could regulate
Notch activation, we demonstrated that eIF3f, known
previously as part of the multiprotein translation initiation
factor eIF3 complex, harbors an enzymatic activity that
acts on Notch. The activated form of Notch is able to
interact with eIF3f only in the presence of the E3 ubiquitin
ligase Deltex, and Notch needs to be deubiquitinated
before it can be cleared and its intracellular domain can
enter the nucleus and fulfill its transcriptional function. Our
results further decipher the molecular mechanisms of
Notch signaling activation, showing that ubiquitination
and deubiquitination events are required. Additionally, we
show that beyond acting as a translation initiation factor,
eIF3f fulfills other functions and has an intrinsic enzymatic
activity.
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PLoS Biology | www.plosbiology.org 2 November 2010 | Volume 8 | Issue 11 | e1000545Figure 1. Identification of eIF3f. (A) Immunofluorescence screen. U2OS cells were transfected with a DE expressing vector together with each
pool of shRNAs targeting the human DUBs. Notch products were detected with anti-myc antibody, or with V1744, to specifically detect NIC
(secondary antibodies were coupled with Alexa-488 and Alexa-555, respectively). Nuclei were stained with Hoechst. (B) Western blot analysis of
endogenous eIF3f and transfected HA-tagged eIF3f in the presence of the pooled (P1 and P2) or the individual shRNA vectors (#1t o#4 from P1, #5
and #6 from P2) targeting eIF3f. a-tubulin loading control is shown. Under the lanes is shown the quantification of the eIF3f bands (overexpressed or
endogenous as indicated), performed with the Quantity One program (Biorad). (C) Quantification of the effect of two shRNA vectors targeting eIF3f
(#3 and #4, respectively, in blue and red) on the extranuclear localization of NIC. Transfection and immunofluorescence were performed as in (A).
400 Notch-positive cells were counted for each point and the percentage of cells showing extranuclear V1744 labeling is shown. Error bars represent
the SEM of duplicate experiments.
doi:10.1371/journal.pbio.1000545.g001
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PLoS Biology | www.plosbiology.org 3 November 2010 | Volume 8 | Issue 11 | e1000545Figure 2. eIF3f is involved in the deubiquitination of activated Notch. HEK293T cells were transfected with: (A) DE, His-ubiquitin, two
increasing doses of eIF3f shRNA #3 (indicated by + and +, respectively), and meIF3f as indicated; (B) DE, DE-LLFF, NIC or Notch full length (FL), His-
ubiquitin, the larger dose of eIF3f shRNA used in (A) (+), and meIF3f as indicated; (C) DE, His-ubiquitin, shRNA #3, and two doses of meIF3f WT or Mut
as indicated by a filled triangle. In all panels, cells were lysed under denaturing conditions and subjected to Nickel purification. Ni-purified material or
WCE (5% of the total lysates) were resolved on SDS-PAGE and analyzed by Western blot using the antibodies indicated on the right of the panels.
Notch p120 designates the membrane-anchored form of non-activated full-length Notch, resulting from furin cleavage. Overexpressed meIF3f has a
higher apparent molecular weight than the endogenous human eIF3f because of its HA tags. White lines indicate that intervening lanes have been
spliced out.
doi:10.1371/journal.pbio.1000545.g002
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(DE
Ub) and of monoubiquitinated NIC (NIC
Ub) (Lanes C, D
compared to B), whereas the levels of Notch in the extracts
remained stable (Lanes G to J). The same effect was observed
using shRNA #4 (unpublished data). Interestingly, overexpression
of meIF3f abolished the effect of shRNA #3 and accumulation of
ubiquitinated Notch could no longer be seen (compare Lanes E to
D). The ubiquitination levels of other forms of Notch were also
analyzed in the presence or absence of shRNA #3 (Figure 2B): the
membrane-anchored DE-LLFF (Lanes D–F), which undergoes the
same processes as DE (i.e., monoubiquitination and endocytosis)
but which is mutated in the c-secretase cleavage site and
consequently does not generate NIC [18]; the nuclear Notch
(NIC, Lanes G–I) and the non-activated full-length Notch (FL,
Lanes J–L). The only forms whose ubiquitination was affected by
shRNA #3 and/or meIF3f were those corresponding to activated
and still membrane-anchored forms of Notch, namely DE and DE-
LLFF. We also tested as controls NDFIP2 (a transmembrane
protein located in the endosomal compartment [19]) and Deltex1
(an E3 ubiquitin ligase genetically identified as involved in Notch
signaling). These two proteins showed no change in ubiquitination
in the presence of shRNA #3 or overexpressed meIF3f (Figure S2
and unpublished data). These results suggest that eIF3f is
specifically involved in an ubiquitination/deubiquitination process
targeting activated Notch.
The eIF3f protein contains an MPN domain, also found in some
DUBs of the JAMM family, such as AMSH, Rpn11, and CSN5
[20–23]. However, the position of the amino acids constituting the
catalytic site of these DUBs is not strictly conserved in eIF3f,
although histidines and acidic residues can still be found and can
possibly form a signature of metalloprotease (HEX2HX2GX2H).
We mutated six amino acids of eIF3f, including two histidines and
two acidic residues of the putative catalytic site. We then tested in
parallel WT meIF3f andthisputative catalytic mutant (meIF3f Mut)
(Figure 2C). Whereas WT meIF3f was able to prevent shRNA #3–
induced NIC
Ub accumulation in a dose-dependent manner (Lanes
D, E compared to C), meIF3f Mut was not, although it was
expressed at similar levels (Lanes D to G). This shows that meIF3f
indeed complements the effect of shRNA #3 and that an intact
MPN domain of eIF3f is necessary for its effect on monoubiquitina-
tion of activated Notch. Taken together, these results strongly
suggest that eIF3f could act as a DUB targeting activated Notch.
eIF3f Harbors a DUB Activity
In order to test whether eIF3f exhibits a deubiquitinase activity,
we first used a functional in bacteria assay using GFP fused to
ubiquitin (Ub-GFP) [24]. The peptide bond between ubiquitin and
GFP can be cleaved by ubiquitin- or UbL-deconjugase activities,
which are absent from the bacterial genome. Bl21 bacteria were
transfected with plasmids encoding GST alone, GST-fused to
human WT eIF3f or WT MPN domain, or His-tagged murine
eIF3f WT or mutant MPN domain (Mut), together with a vector
encoding Ub-GFP fused to an S-Tag at its C-terminus (Ub-GFP-
S-Tag) (Figure 3A). As control DUB, we used BPLF1 WT (an EBV
DUB of the cysteine-protease family [24]) and its catalytically
inactive form BPLF1 CM. After induction of protein expression,
the bacteria were lysed and cleavage of Ub-GFP was assessed in
Western blot by the appearance of free GFP-S-Tag using anti-S-
Tag antibody (Figure 3A, upper panel). Anti-GST or anti-His
antibodies were used to verify protein expression (Figure 3A,
bottom panel). As expected, we observed released GFP with
BPLF1 WT but not its CM mutant (compare Lanes A–C).
Interestingly, we also detected protease activity with heIF3f WT,
heIF3f MPN WT, and meIF3f MPN WT (Lanes D, E, and F,
respectively) but not with the mutant meIF3f MPN Mut (Lane G).
To further investigate whether eIF3f could act as an ubiquitin-
specific protease, we performed an in vitro assay using Ubiquitin
Vinyl Sulfone (Ub-VS), a functional probe that covalently binds
the active site of DUBs and consequently inhibits DUB catalytic
activity (Figure 3B). HeLa cells were transfected with vectors
encoding HA-tagged meIF3f, either WT or Mut. Flag-tagged
BPLF1 WT and CM were used as controls. A portion of the
corresponding whole cell extracts was incubated in vitro with Ub-
VS. Total extracts incubated or not with Ub-VS were finally
analyzed by Western blot using anti-HA and anti-Flag antibodies
to monitor the covalent binding of Ub-VS to the DUBs (Figure 3B,
Lanes A to H) and to check protein expression (Lanes I to N),
respectively. We observed a partial upshift corresponding to the
size of the Ub-VS probe with meIF3f WT (Lane F compared to E)
and with BPLF1 WT (Lane B compared to A), indicating that both
are able to bind Ub-VS. In contrast, we did not observe any shift
with meIF3f Mut (Lane H compared to G) nor BPLF1 CM (Lane
D compared to C), showing that they are indeed unable to bind
Ub-VS. We obtained the same results when the DUBs were
expressed in bacteria (unpublished data).
Taken together, these results show that eIF3f exhibits a
deubiquitinase activity, carried by its MPN domain. Moreover it
confirms that the mutant we generated (Mut) by replacing six
amino acids of the metalloprotease-like sequence of eIF3f is a
catalytically inactive form of eIF3f.
Deltex1 Is an Intermediate between eIF3f and Notch
In order to identify the site of action and the target of eIF3f in
the Notch activation cascade, we first overexpressed DE and
murine eIF3f in U2OS cells. We observed by immunofluorescence
a low frequency of vesicular colocalization of the two proteins
(Figure 4, Panels A and B). As eIF3f might require a cofactor or
target an intermediate protein to regulate Notch ubiquitination,
we tested several components of the Notch signaling pathway that
could be associated with trafficking. Some DUBs are known to be
recruited to their substrate indirectly via an E3 ubiquitin ligase
[25,26], so we particularly focused on the E3 ubiquitin ligases of
the Notch pathway known to be associated with the endocytic
machinery: Itch/AIP4 and Deltex1 (hereafter designated as DTX)
([27] and therein). In contrast to Itch/AIP4, DTX significantly
colocalized with eIF3f when both proteins were coexpressed
(Figure 4, Panel C). In addition, the presence of DTX strikingly
increased the colocalization of DE and eIF3f, the three proteins
being associated to the same vesicles (Figure 4, Panel D). These
results suggest that DTX could recruit eIF3f to activated Notch.
To verify this hypothesis, we performed co-immunoprecipita-
tion experiments in HEK293T cells transfected with vectors
encoding VSV-tagged DTX, Flag-Itch/AIP4, and HA- or Flag-
tagged forms of eIF3f (schematized in Figure 5A). We pulled down
eIF3f and analyzed the whole cell extracts and the immunopre-
cipitates by Western blot (Figure 5B, 5C and Figure S3). DTX co-
immunoprecipitated with eIF3f WT and (1–192), but also with
eIF3f (188–361) and (91–361) (compare Lanes B, C to D, E in
Figure 5B and 5C). No co-immunoprecipitation was detected with
Itch/AIP4 (Figure S3). As a control, the endogenous eIF3a,
another subunit of the eIF3 complex, only co-immunoprecipitated
with eIF3f WT and (91–361) (Panels B, C). This observation
suggests that DTX is able to physically interact with eIF3f and that
the domain(s) necessary for this interaction is different from the
domain necessary for eIF3f to incorporate the eIF3 complex. We
then performed the reverse experiment by pulling down VSV-
tagged DTX and could detect the various forms of eIF3f
eIF3f, a DUB in Notch Signaling
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(Lanes B, C) as well as the deletion mutants (Lanes D–F). To
confirm these results under conditions where the proteins are not
overexpressed, we established by retroviral transduction murine
cell lines expressing low amounts of VSV-DTX and S-tagged
forms of WT eIF3f or of a mutant of the active site (HDI to AAA).
eIF3f or DTX was immunoprecipitated first and their association
was confirmed in both cases (Figure 5E).
We then performed co-immunoprecipitations in HEK293T in
the presence of Notch DE (Figure 6A). While DTX co-
Figure 3. eiF3f DUB activity. (A) eIF3f exhibits a DUB activity in a bacterial Ub-GFP assay. Bl21 bacteria were transformed with Ub-GFP-S-Tag
plasmid and either GST-fusions or His-fusions as indicated. After protein expression induction, they were lysed by sonication. WCE were analyzed by
Western blot using the antibodies indicated under each panel to visualize GFP release from Ub-GFP (WB S-Tag) and to control protein expression (WB
GST and His). The GFP product resulting from the DUB activity and the Ub-GFP substrate are indicated by the arrows. (B) eIF3f binds ubiquitin in an
eukaryotic Ub-VS assay. HeLa cells were transfected with expression vectors encoding BPLF1 WT or CM (Lanes A–D, J, K), or meIF3f WT or Mut (Lanes
E–H, M, N) as indicated. 36 h after transfection, 10 mg of WCE were incubated (or not) with Ub-VS probe (Lanes A to H). Samples were finally analyzed
by Western blot as indicated under the panels to monitor Ub-VS binding (Lanes A to H) and to check protein expression (Lanes I to N). b-Actin was
used as a loading control. The apparent molecular weights of BPLF1 and meIF3f are 32 kDa and 50 kDa, respectively.
doi:10.1371/journal.pbio.1000545.g003
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(Figure 6A, Lanes B–E), DE didnot (Lanes I and J),unlessDTX was
cotransfected (Lanes D and E). This strongly suggests that a
tripartite interaction occurs between activated Notch, DTX, and
eIF3f, DTX being required for the Notch-eIF3f interaction. In
addition, we verified that neither DTX nor DE could be co-
immunoprecipitated with eIF3f from cell extracts that were
transfected separately and mixed (unpublished data). We then
repeated these experiments using other forms of Notch: DE-LLFF,
NIC, or the non-activated full-length Notch (FL) (Figure 6B). Only
two forms could co-immunoprecipitate with eIF3f in the presence of
DTX: DE and DE-LLFF (Lanes C and D). No signal was detected
with FL and NIC (Lanes E and F) even with a longer exposure. It is
of note that NIC produced from DE (Lanes C, G) and detected by
the V1744 antibody was not co-immunoprecipitated with eIF3f
either. These results show that the tripartite interaction between
Notch, DTX, and eIF3f occurs preferentially with activated,
membrane-associated, but c-secretase unprocessed, forms of Notch.
Our results (Figures 2 and 6) suggest that the target of eIF3f is
preferentially a c-secretase unprocessed form of activated Notch.
The fact that we could detect ubiquitinated NIC in the presence of
shRNAs #3 and #4 (Figure 2A) might thus appear paradoxical,
however it might be the consequence of c-secretase cleavage of
non-deubiquitinated Notch DE. We also observed that shRNAs
#3 and #4 led to a partially extranuclear localization of NIC
(Figure 1C). This suggests that NIC carrying residual mono-
ubiquitination could be impaired in nuclear translocation. In order
to test this possibility, we tried to mimic NIC
Ub by attaching an
ubiquitin to the N-terminus of NIC (UBIC construct). Given that
DE, and consequently any putative non-deubiquitinated NIC, has
been shown to be monoubiquitinated on K1749, we used a
K1749R mutant of NIC (NIC(KR)) on which no ubiquitin can be
conjugated. In addition, the attached ubiquitin was mutated on
the internal Lysine residues 29 and 48 to impair polyubiquitina-
tion and also on the 2 C-terminal glycines to prevent proteolysis by
a DUB enzyme [28]. U2OS cells were transfected with NIC,
NIC(KR), or the new construct UBIC. We observed by
immunofluorescence that NIC or NIC(KR) were mostly nuclear
(96% in average), whereas UBIC was partially retained in the
cytoplasm (18% see Figure S4, Panel A). In addition, we
monitored the transcriptional activity of these three forms by
cotransfecting U2OS cells with increasing doses of expression
Figure 4. Colocalization of eIF3f, DTX,and DE. U2OS cells were transfected with expression vectors as indicated on the left. eIF3f, DTX, and DE were detected
using mouse anti-HA, rabbit anti-VSV, and goat anti-myc, respectively (with CY3-coupled, Alexa 488-coupled, and Alexa 647-coupled secondary antibodies,
respectively). Insets represent enlargements (4-fold) of the boxed region, arrows indicate colocalizations, and left panels are merges of the three adjacent panels.
doi:10.1371/journal.pbio.1000545.g004
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PLoS Biology | www.plosbiology.org 7 November 2010 | Volume 8 | Issue 11 | e1000545Figure 5. Interactions of eIF3f and DTX. (A) Schematic representation of murine eIF3f deletion mutants. The conserved MPN domain is depicted
in blue; amino acid coordinates are indicated. (B) HEK293T cells were cotransfected with vectors encoding HA-tagged eIF3f WT or (1–192), and VSV-
tagged DTX. Whole cell extracts (WCE, 5% of the lysates) were either directly blotted with antibodies indicated on the right of the lanes or
immunoprecipitated first with anti-HA antibody. b-tubulin was used as a loading control. (C) HEK293T cells were cotransfected with vectors encoding
Flag-tagged eIF3f (188–361) or (91–361), and VSV-tagged DTX. WCE (5%) were either directly blotted with antibodies indicated on the right of the
lanes or immunoprecipitated first with anti-Flag antibody. b-tubulin was used as a loading control. (D) HEK293T cells were cotransfected with vectors
encoding the various eIF3f mutants and VSV-DTX. WCE were immunoprecipitated with anti-VSV antibody, and the precipitates were eluted with VSV
peptide before being loaded on SDS gels. The eluted material and the WCE (5% of the lysates) were analyzed by Western blotting with antibodies
eIF3f, a DUB in Notch Signaling
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[29,30]) and an internal control reporter (pRL-TK). As shown in
Figure S4, Panel B, UBIC is significantly less active than NIC or
NIC(KR), although it is expressed at a comparable level (see
Western blot in Figure S4, Panel B bottom). One possibility to
explain the localization and the drop in transcriptional activity of
UBIC is that the ubiquitin moiety partially prevents access to the
NLS of NIC.
eIF3f Is a Positive Regulator of Notch Signaling
In order to test whether eIF3f could act on Notch signaling
under more physiological conditions, we performed a coculture
assay using a CSL reporter strategy. U2OS cells stably expressing
Notch FL were transfected with a CSL-Luciferase Notch reporter
and increasing doses of meIF3f WT, meIF3f Mut, or meIF3f (188–
361). pRL-TK vector, encoding Renilla luciferase under the
control of the Notch-insensitive thymidine kinase promoter, was
also cotransfected as an internal control. These cells were then
cocultured with OP9 cells stably expressing or not the Notch
ligand Delta-like1 (Dll1) [31], and relative luciferase activity was
finally determined by normalizing CSL-firefly luciferase with
renilla luciferase. In parallel cell extracts from the same
transfections were analyzed by Western blot (Figure 7A, bottom).
In the presence of Dll1, the relative luciferase activity of the CSL
reporter gene increased 20-fold (Figure 7A, Lanes A, B), showing
that Notch was indeed activated by Dll1. While the presence of
meIF3F WT did not modify Dll1-dependent Notch activation
(Lanes C to F), meIF3F Mut and meIF3f (188–361) repressed it in
a dose-dependent manner, respectively, reaching 35% and 54% of
reduction (Lanes G–J and K–N, respectively). Thus, meIF3f Mut
and meIF3f (188–361) inhibit Notch transcriptional activity and
behave as dominant-negative forms of eIF3f, in accordance with
the fact that both lack an intact catalytic site but are able to bind
DTX and Notch. We also tested the effect of shRNAs targeting
endogenous eIF3f in this assay. As represented in Figure 7B, Dll1-
induced Notch stimulation was inhibited in the presence of
increasing doses of either P2 (Lanes C–E) or shRNA #1 (Lanes F–
H), although Notch1 overall level remained constant (see bottom
of Figure 7B). In contrast, a shRNA pool targeting AMSH,
another DUB of the JAMM family, had no effect on Notch
activation (Lanes I–K). Furthermore, the same shRNAs have no
effect on NIC-mediated transcriptional activation (Figure S5),
excluding any effect of the shRNAs on Notch-associated
transcription factors. Therefore, inhibition of eIF3f DUB activity
impairs the production of a transcriptionally active NIC in a dose-
dependent manner.
All together, our results indicate that eIF3f, after being recruited
to vesicular Notch via DTX, could act as a DUB on a
monoubiquitinated but not c-secretase processed form of Notch,
thus positively modulating Notch signaling activity.
Discussion
A DUB Acting during Notch Activation
With the aim of identifying a DUB that could regulate Notch
activation, we reached two new and provocative conclusions: the
activated form of Notch needs to be deubiquitinated to enter the
nucleus and fulfill its transcriptional function, and the DUB
accounting for this activity is eIF3f, known so far as a translation
initiation factor. When reconstituting a Notch activation system by
co-culturing Notch1 receptor- and Dll1 ligand-expressing cells, we
observed that Notch-dependent transcriptional activation of a
reporter gene was specifically affected when expressing mutant
forms of eIF3f where the active site was mutated or when eIF3f
was partially knocked down. Therefore eIF3f acts as a positive
regulator of Notch signaling, independently of its function in
translation (see below). We have also demonstrated that a
monoubiquitinated form of Notch DE was stabilized when eIF3f
was slightly knocked down. This effect was accompanied by the
appearance of a mono-ubiquitinated form of NIC, which is
probably excluded from the nucleus. Therefore we conclude that
Notch deubiquitination is necessary for its full activity in the
nucleus.
We have not formally identified the form of Notch that is the
substrate of the DUB activity. We cannot exclude that it is a
monoubiquitinated non-nuclear NIC, resulting from c-secretase
cleavage of activated Notch. Such a form has never been detected
before, in contrast to the nuclear polyubiquitinated NIC, which
appears subsequently under the action of the E3 ubiquitin ligase
Sel10 [32,33]. An artificial construct mimicking to a certain extent
the monoubiquitinated NIC (UBIC) was partially retained in the
cytoplasm and as a consequence was transcriptionally less active
than NIC. This suggests that the ubiquitin moiety could mask the
proximal NLS [34] and impair interaction with importins.
Nevertheless three observations argue against the possibility of
NIC being the natural substrate of eIF3f: first, NIC was not
obviously associated with endosomes when it was excluded from
the nucleus in the presence of eIF3f shRNA. As eIF3f colocalizes
with Notch to endosomal structures, its target should be retained
to these structures (Figure 4). Second, NIC produced from DE was
not detected as coimmunoprecipitating neither with eIF3f nor with
its mutant in the presence of DTX, which would have probably
been the case if it were the DUB substrate (Figure 6). And third,
the effect of shRNAs targeting eIF3f were only detected on
activated but still membrane-anchored forms of Notch, including
one unable to produce NIC (DE-LLFF, see Figure 2). Therefore
we favor the hypothesis that the eIF3f substrate is the activated,
monoubiquitinated but still membrane-anchored Notch (mim-
icked by DE in transfection experiments, see [8]). The presence of
monoubiquitinated NIC when eIF3f activity is impaired would be
due to a partial activity of c-secretase on non-deubiquitinated DE.
Finally, our results show that eIF3f is recruited to Deltex1 and
Notch DE-containing vesicles in transfected cells. They can thus
form a tripartite complex where DTX serves as a bridging factor
between Notch and eIF3f. Deltex1 belongs to the RING family of
E3 ubiquitin ligase, however its target in Notch signaling remains
to be determined [35]. It localizes to the endocytic pathway [27],
interacts with Notch, and thus could serve as a scaffolding protein
enabling Notch trafficking and modifications, and eventually
Notch signaling.
eIF3f Is a DUB
Our results suggest that eIF3f, known so far as a component of a
translation initiation factor complex, is itself able to act as a DUB
indicated on the right of the lanes. a-tubulin was used as a loading control. (E) Stable cell lines derived form MEFs by retroviral transduction of VSV-
DTX or S-tagged eIF3f (either WT or active site mutant) were lysed and subjected to parallel immunoprecipitations with VSV and S-tag antibodies as
indicated. The VSV- or Laemmli-eluted material (for VSV and S-tag IPs, respectively) and the WCE (5% of the lysates) were analyzed by Western
blotting with antibodies indicated on the right of the lanes. a-tubulin was used as a loading control. White lines indicate that intervening lanes have
been spliced out.
doi:10.1371/journal.pbio.1000545.g005
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a WT form of eIF3f is able to complement the inhibition of activity
mediated by eIF3f shRNAs and to restore deubiquitination of
Notch DE. However we cannot completely rule out the possibility
that another DUB, associated with eIF3f, could account for Notch
Figure 6. Interaction of eIF3f and activated Notch in the
presence of DTX. HEK293T cells were cotransfected with vectors
encoding HA-tagged forms of eIF3f (either WT or Mut in Panel A), VSV-
DTX, and myc-tagged Notch constructs (DE, DE-LLFF, NIC, or FL in Panel
B) as indicated above the lanes. Immunoprecipitations were performed
with anti-HA antibody. In both panels, immunoprecipitates and WCE
(10% of the lysates) were analyzed by Western blot as indicated. a-o rb-
tubulin were used as loading controls.
doi:10.1371/journal.pbio.1000545.g006
Figure 7. Notch-Delta coculture assay. Modulation of the Notch
reporter activity (CSL-luciferase) in Notch1-expressing cells cocultured
with Dll1-expressing cells (Lanes B–N) or control cells (Lane A). The
Notch-expressing cells were first transfected with both CSL-firefly
luciferase (Notch reporter) and TK-renilla luciferase (internal control)
24 h before coculture. The CSL-reporter activation corresponds to the
ratio between Firefly and Renilla luciferase activities. The relative
luciferase activity in the presence of Dll1-expressing cells (Lane B) was
defined as 100%. Error bars represent the SEM of triplicate experiments.
(A) Effects of increasing doses of expression vectors encoding eIF3f WT
(Lanes C–F), Mut (G–J), or (188–361) (K–N) in reporter cells are shown as
indicated. Expression levels of eIF3f, Notch, and Dll1 were confirmed by
Western blot analysis, using b-tubulin as a loading control. White lines
indicate that intervening lanes have been spliced out. (B) shRNAs
targeting eIF3f decrease Notch signaling. Increasing doses of eIF3f
shRNA P2 (C–E), shRNA #1 (F–H), or a control pool targeting AMSH (I–K)
were transfected into the Notch-expressing cells as above. Bottom
shows the Western blot analysis of a representative experiment.
doi:10.1371/journal.pbio.1000545.g007
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in addition to its own isopeptidase activity, is associated with
USP15, both being required for proper processing of polyubiqui-
tinated substrates bound to p97/VCP [36–38]. Such a putative
eIF3f-associated DUB, the knockdown of which would not affect
protein translation, should have been identified during the screen.
Moreover, eIF3h, the other MPN-containing subunit of eIF3
associated with eIF3f [12], has neither histidines nor acidic
residues that could confer a DUB activity. The fact that eIF3f was
the only DUB identified argues against the possibility of an
associated DUB. eIF3f was not identified in other screens, in
particular in one recently performed in Drosophila [39], probably
because a strong extinction of this translation factor had a more
severe and broad phenotype than a Notch phenotype, even on
external sensory organ development. We actually were able to pick
up this factor thanks to the presence of relatively inefficient
shRNAs in the library.
The human genome encodes 14 JAMM proteins, seven of
which have a complete set of the conserved residues for Zn2+
coordination [40]. Among them, six (AMSH, AMSH-LP,
BRCC36, Rpn11, MYSM1, and CSN5) have been reported to
have isopeptidase activity on ubiquitin or ubiquitin-like proteins. It
is of note that the JAMM sequence of eIF3f cannot be aligned with
those of the proteins constituting the MPN+ group (Rpn11, Csn5,
AMSH; see [15]). Nevertheless the four polar and the additional
glutamate residue in a more N-terminal region of the domain are
still present in eIF3f, although not arranged in the MPN+-defined
pattern, and the mutation of some of these amino acids affects
eIF3f enzymatic activity and function in Notch signaling. It must
be noted that the MPN+ consensus domain has been generated
using a small number of proteins and that divergent members may
well exist, including eIF3f.
Using an in bacteria assay, we have demonstrated that full-
length eIF3f or its isolated MPN domain exhibit DUB activity and
that the active site indeed involves the amino acids that we had
targeted in our inactive mutant. The relatively low activity that we
detected in this assay, as compared to the BPLF1 control, might
be due to the specificity of this DUB, which is limited by the
nature of the P’1 and P’2 residues in the substrate sequence, thus
preventing cleavage of non-specific substrates. However we have
confirmed by Ub-VS fixation that WT but not mutant eIF3f
exhibits DUB activity in mammalian cells. Among the members
of the JAMM family, AMSH and AMSH-like seem to be specific
for Lys63-linked polyubiquitin chains [41], while MYSM1 is
specific for monoubiquitinated H2A [42]. Sato et al. [43]
suggested that the specificity of AMSH family members for
Lys63-linked polyubiquitin chains is primarily due to their
interaction with the proximal ubiquitin, involving a single domain
containing two characteristic insertions that are not conserved in
eIF3f. However, DUBs may have a multidomain structure, and
someofthemassociate withother proteins, including E3 ubiquitin
ligases [23,44]. We show that Notch is only able to interact with
eIF3f in the presence of the E3 ubiquitin ligase DTX and that a
monoubiquitinated form of Notch is probably the substrate
targeted by the DUB. Therefore any reconstituted in vitro system
will be difficult to set up.
As JAMM DUBs are commonly found in association with large
protein complexes, on one hand, and eIF3f belongs to the eIF3
complex, on the other hand, it will be of great interest to
determine whether eIF3f can work as a DUB outside of the
translation complex or whether the active form of eIF3f is
associated with the whole translation initiation complex. If it were
the case, beside an analogy and homology in the molecular
architecture of the other Zomes members (Cop9 signalosome and
proteasome, [45]), eIF3 would also harbor an enzymatically-
conserved organization.
Do Translation Factors Have Multiple Functions?
Beyond acting as a translation initiation factor, eIF3f fulfills
other functions, probably independently of the eIF3 complex. For
instance, it was shown to inhibit HIV-1 replication [46] by
modulating the sequence-specific recognition of the HIV-1 pre-
mRNA by the splice factor 9G8. It was also recently proposed to
serve as a scaffold in coordinating mTor and SGK1 actions on
skeletal muscle growth [47] and to interact genetically and
physically with TRC8, an E3 ubiquitin ligase of the RING family
with several TM domains [48]. On the other hand, there are at
least two different types of eIF3 complexes in the cell, localized in
different subcellular fractions. One complex lacks eIF3a and eIF3f,
while the other consists of eIF3a–c and eIF3f. Phosphorylated
eIF3f may predominantly localize to the nucleus and join a
complex containing at least b and c during apoptosis. Therefore,
the nuclear eIF3 complex is likely to have functions other than
translation initiation [49]. In yeast, affinity purification and LC-
MS/MS was employed to characterize the eIF3 interactome,
which was found to contain 230 proteins [50]. This led to the
proposal that eIF3 assembles into a large supercomplex, the
translasome, which contains elongation factors, tRNA synthases,
40S and 60S ribosomal proteins, chaperones, and the proteasome.
On the other hand, eIF3 also associates with importins-b, a critical
event for normal cell growth. These data suggest that translasomes
are dynamically localized within the cell, and eIF3 could shuttle
between the cytoplasm and the nucleus in a cell cycle-dependent
manner. All these data are in agreement with the hypothesis that
eIF3f, and maybe part of eIF3, could have multiple functions in
the cells. Our results now add an enzymatic activity to these
various properties; it remains to be elucidated whether this activity
is necessary to fulfill all eIF3f functions.
Recent data suggest that other translation factors, many of
which exist in several copies in the genome (as does eIF3f), have
‘‘part-time jobs’’ outside of their usual function in translation [51].
It is the case, for example, for eIF4A, which exhibits an RNA
helicase activity in translation initiation and which was shown to
act in a translation-independent manner as a negative regulator of
Dpp/BMP signaling in drosophila [52]. eIF4A affects Mad protein
level and was suggested to act as an E3 ubiquitin ligase.
In parallel also to ribosomal proteins, which have been recently
shown to function outside of the ribosome and to be recruited in
some cases for a function unrelated to the ribosome or its synthesis
[53], we propose that eIF3f would be another example of a
housekeeping protein that also plays a specific role in the Notch
signaling pathway.
Materials and Methods
shDUB Library
shDUB library was described in [10] (see also [40,54,55]).
Additive shRNAs are listed in Table 1. The pool targeting AMSH
used as a control in Figure 7B is the number 139 of the library.
Constructs
All myc-tagged Notch constructs (DE, DE-LLFF, FL, and NIC)
were already described [18,56] and were gifts from R. Kopan
(Washington University, St. Louis, MO). These Notch constructs
are all deleted from aa 2183 of murine Notch1 and fused to a
hexameric myc tag at the carboxy terminus. Notch1 retroviral
vector encodes a full-length human Notch1 with an HA-epitope
eIF3f, a DUB in Notch Signaling
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Harvard medical school, Boston, USA).
All WT and deletion mutants of eIF3f (containing N-terminal
tags), as well as GST-fused eIF3f constructs, were gifts from S.
Leibovitch (Montpellier, France), except the catalytic mutant.
meIF3f Mut was generated from HA-tagged WT meIF3f by two
successive site-directed mutagenesis using, respectively, the
oligonucleotides 59-GCCACAGGCGCTGCAGCCACAGAA-
CACTCAGTGCTG-39 and its complementary DNA, and 59-
GACATCACAGCTGCAGCCCTGCTGATCCATGAG-39 and
its complementary DNA (HDI(aa181–183) mutated in AAA and
IHE(aa190–192) mutated in GIL). 6xHis-tagged Ubiquitin
construct was a gift from M. Treier (European Molecular Biology
Laboratory, Heidelberg, Germany).
HIS-tagged eIF3f MPN constructs were built by inserting the
amino acids 95 to 226 of meIF3f WT or meIF3f Mut in pet28a
vector using NdeI and BamHI restriction sites.
Retroviral meIF3f vectors were constructed first by adding a S-
Tag in the N-terminus end of meIF3f WT or meIF3f mutated in
the catalytic domain (HDI (aa181–183) mutated in AAA). Then S-
tagged meIF3f constructions were inserted in pMSCVpuro vector
using HindIII and ClaI restriction sites. The puromycin resistance
gene was replaced by S-Tagged meIF3f, whose expression is by the
way under the control of PGK promoter.
CSL-Luc was a gift from T. Honjo (Kyoto University, Japan)
and is referred to as pGa981-6 in [30]. NDFIP2 was a gift from S.
Kumar (Adelaide University, Australia) and is referred to in [19].
Both BPLF1 constructs were described in [24].
Antibodies
We used anti-myc 9E10 and anti-VSV P5D4 antibodies. Anti-
Notch IC and anti-Dll1 antibodies were described, respectively, in
[57] and [31].
Other antibodies for Western blot were supplied by Abcam
(polyclonal anti-S-Tag), Bethyl (polyclonal anti-eIF3a), BioLegend
(polyclonal anti-eIF3f), Cell Signaling (anti-Notch V1744), Cov-
ance (monoclonal anti-HA; polyclonal anti-HA), Invitrogen
(polyclonal anti-GFP), Novagen (monoclonal anti-S-Tag), and
Sigma (monoclonal anti-Flag M2; polyclonal anti-Flag; monoclo-
nal anti-b-tubulin; monoclonal anti-a-tubulin, monoclonal anti-b-
Actin). Secondary antibodies for immunofluorescence were
supplied by Molecular Probes (Alexa Fluor conjugates).
Cell Lines
U20S-FL cell line was established by retroviral transduction.
High titers of recombinant HA-tagged Notch FL viruses were
obtained 48 h after transfection of the Plat-E ecotropic packaging
cell line with retroviral expression plasmids. After retroviral
transduction of the U2OS cell line, clonal populations were
obtained by limiting dilution. OP9-Dll1 cell line was described in
[31].
MEFs stably expressing VSV-DTX and S-Tag-meIF3f were
established from the DTX-expressing MEFs [27] by retro-
transduction of S-tagged meIF3f vectors.
Immunofluorescence Assays
U2OS cells were grown on glass coverslips and were transiently
transfected using FuGeneHD transfection reagent (Roche, Mann-
heim, Germany) for 24 h. Cells were fixed with 4% paraformal-
dehyde and permeabilized with PBS containing 0.2% Triton X-
100 for 5 min before the incubation with appropriate antibodies.
Cell preparations were mounted in Mowiol (Calbiochem, Merck
Biosciences, Darmstadt, Germany) and images acquired using an
AxioImager microscope with ApoTome system with a 636
magnification and AxioVision software (Carl Zeiss MicroImaging
Inc., Le Pecq, France).
Ubiquitin-Conjugates Purification
293T cells were harvested 24 h after transfection and lysed in
8 M urea, 0.1 M NaH2PO4, 10 mM Tris-Hcl (pH 8), 1% Triton
X-100, and 20 mM Imidazole at room temperature. His-Ub
conjugated proteins were purified on chelating Sepharose beads
(Pharmacia), previously charged with Nickel. Ni-bound proteins
were washed extensively with the same buffer, then with a pH 6.3
buffer, and eluted in Laemmli before Western blot analysis.
Cell Extracts, Immunoprecipitations, and Immunoblots
293T cells were collected 24 h after transfection, washed in
PBS buffer, and lysed in 50 mM Tris-HCl (pH 7,9), 400 mM
NaCl, 5 mM MgCl2, 1% Triton X-100, supplemented with
protease inhibitor cocktail (Roche). Cell extracts were cleared by
centrifugation at 14,000 rpm for 20 min at 4uC. Immunopre-
cipitations were performed with the appropriate antibodies in the
same buffer. When indicated, the immunoprecipitates were
eluted by peptide competition (2 mg/mL) for 1 h at 4uC.
Samples were denatured in Laemmli buffer for SDS-PAGE
resolution, and immunoblots were performed as described
previously [18].
Deconjugase Activity Assays
In bacteria functional assay: Bl21 bacteria were transfected with
GST-fusions or His-tagged encoding vectors together with Ub-
GFP plasmid. The bacteria were selected on agar plates and
cultured in LB medium containing Chloramphenicol and
Ampicillin or Kanamycin. Exponential bacteria cultures
(OD=0.4) were treated with IPTG 0.5 mM for 16 h at 23uC.
Bacteria were harvested, washed, resuspended in PBS containing
20 mM N-Ethylmaleimide, and sonicated for 30 s on ice. After
centrifugation (12,000 rpm, 10 min), clear supernatants were
measured for GFP fluorescence and protein concentration.
Samples were analyzed by two SDS-PAGE resolutions using for
each sample 100 units of fluorescence for Ub-GFP assay and 10 mg
extracts for protein expression analysis.
Ub-VS assay: HeLa cells were collected 36 h after transfection,
washed with PBS, and lysed in 50 mM Tris-Cl pH 7.4, 150 mM
NaCl, 1 mM DTT, 1 mM EDTA, 1 mM PMSF, and 0.5%
NP40. Protein concentrations were measured. 10 mg of WCE were
incubated for 1 h at 37uC with 1 mg of Ub-VS functional probe
(Boston Biochem) in a 30 mL final volume of labeling buffer
(50 mM Tris-Cl pH 7.4, 250 mM sucrose, 5 mM MgCl2, and
1 mM DTT). Finally, WCE and Ub-VS-treated samples were
analyzed by Western blot.
Coculture Assay
20,000 U2OS-FL cells/cm
2 were grown and transiently
transfected using FuGeneHD transfection reagent (Roche, Mann-
heim, Germany). 24 h after transfection, U2OS-FL cells were
cocultured with 35,000 OP9-Dll1 cells/cm
2. 18 h later, cocultures
(done in triplicates) were lysed using Passive Lysis buffer
(Promega). A fraction of cell lysates were transferred to a white
96-well plate (Berthold). Firefly and Renilla luciferase activities
were measured using the luminometer Centro XS (Berthold). For
Western blot analysis, part of cocultures were lysed with 8 M urea,
0.1 M NaH2PO4, 10 mM Tris-Hcl (pH 8), 1% Triton X-100,
and 20 mM Imidazole.
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DUB Enzyme (Putative)/Sense Oligo Sequences Ensembl Gene ID
Ataxin-3-like ENSG00000123594
GATCCCCCATGGATGATACCGGTTTCTTCAAGAGAGAAACCGGTATCATCCATGTTTTT
GATCCCCGCTGACCAACTCCTGCAGATTCAAGAGATCTGCAGGAGTTGGTCAGCTTTTT
GATCCCCCCAATAGAGAAGATGAACATTCAAGAGATGTTCATCTTCTCTATTGGTTTTT
GATCCCCCAACAAGTTCGAGAGCAATTTCAAGAGAATTGCTCTCGAACTTGTTGTTTTT
Ataxin-3 ENSG00000066427
GATCCCCGCAGATCTCCGCAGGGCTATTCAAGAGATAGCCCTGCGGAGATCTGCTTTTT
GATCCCCGCAAATGATGGCTCAGGAATTCAAGAGATTCCTGAGCCATCATTTGCTTTTT
GATCCCCATCTTACTTCAGAAGAGCTTTCAAGAGAAGCTCTTCTGAAGTAAGATTTTTT
GATCCCCCTCCTGCAGATGATTAGGGTTCAAGAGACCCTAATCATCTGCAGGAGTTTTT
JOSD3 ENSG00000166012
GATCCCCCTCTTCTGATAGCAGCTTATTCAAGAGATAAGCTGCTATCAGAAGAGTTTTT
GATCCCCTCATTGAAGCAAATGAATGTTCAAGAGACATTCATTTGCTTCAATGATTTTT
GATCCCCGACCAGAAGGAAGGAGAAATTCAAGAGATTTCTCCTTCCTTCTGGTCTTTTT
GATCCCCTTCCCTGTAAGACTGAGTGTTCAAGAGACACTCAGTCTTACAGGGAATTTTT
HIN-1 ENSG00000164164
GATCCCCCAGAGAGAAATTTGAAGCGTTCAAGAGACGCTTCAAATTTCTCTCTGTTTTT
GATCCCCAGTATAAAGAAAGCTCTGCTTCAAGAGAGCAGAGCTTTCTTTATACTTTTTT
GATCCCCAAGTGCCCTTTCTCTTATGTTCAAGAGACATAAGAGAAAGGGCACTTTTTTT
GATCCCCAAGAAAGCTCTGCTATGTGTTCAAGAGACACATAGCAGAGCTTTCTTTTTTT
Otubain-1 ENSG00000167770
GATCCCCGACCAGGCCTGACGGCAACTTCAAGAGAGTTGCCGTCAGGCCTGGTCTTTTT
GATCCCCGAGCAAGGAAGACCTGGTGTTCAAGAGACACCAGGTCTTCCTTGCTCTTTTT
GATCCCCGAGATTGCTGTGCAGAACCTTCAAGAGAGGTTCTGCACAGCAATCTCTTTTT
GATCCCCGTTCTTCGAGCACTTCATCTTCAAGAGAGATGAAGTGCTCGAAGAACTTTTT
Otubain-2 ENSG00000089723
GATCCCCGACTTCTGCACTCACGAAGTTCAAGAGACTTCGTGAGTGCAGAAGTCTTTTT
GATCCCCGTGGAGTACGTGGACGAGATTCAAGAGATCTCGTCCACGTACTCCACTTTTT
GATCCCCGGATGGCTCAGTGTCCAGCTTCAAGAGAGCTGGACACTGAGCCATCCTTTTT
GATCCCCCCGAGCAGACTTCTTCCGGTTCAAGAGACCGGAAGAAGTCTGCTCGGTTTTT
RPN8 ENSG00000103035
GATCCCCGTCAATGCCAGGGAAAGAATTCAAGAGATTCTTTCCCTGGCATTGACTTTTT
GATCCCCGCTTCTGGATATCAGGAGCTTCAAGAGAGCTCCTGATATCCAGAAGCTTTTT
GATCCCCGAAAGTACTTGATGTATCGTTCAAGAGACGATACATCAAGTACTTTCTTTTT
GATCCCCGAATGACATTGCCATCAACTTCAAGAGAGTTGATGGCAATGTCATTCTTTTT
TL132 ENSG00000188933
GATCCCCGACACTCATATTAAGCCTATTCAAGAGATAGGCTTAATATGAGTGTCTTTTT
GATCCCCAGATGGCAGACACAAGCAGTTCAAGAGACTGCTTGTGTCTGCCATCTTTTTT
GATCCCCGAAGACAGCACTGATGACCTTCAAGAGAGGTCATCAGTGCTGTCTTCTTTTT
GATCCCCCCCAAACTGCAAGTGGTACTTCAAGAGAGTACCACTTGCAGTTTGGGTTTTT
TRABID ENSG00000019995
GATCCCCGGAGGAACTTGAAGTAGACTTCAAGAGAGTCTACTTCAAGTTCCTCCTTTTT
GATCCCCGTGGTTCAAGTGATGTTGGTTCAAGAGACCAACATCACTTGAACCACTTTTT
GATCCCCGTGTATTCCAGCAATGGTGTTCAAGAGACACCATTGCTGGAATACACTTTTT
GATCCCCGAAGACTGGGCATTTATACTTCAAGAGAGTATAAATGCCCAGTCTTCTTTTT
USP42 ENSG00000106346
GATCCCCCCAAGAAGATGCCCATGAATTCAAGAGATTCATGGGCATCTTCTTGGTTTTT
GATCCCCCTGTAACCTCTCTGATCGGTTCAAGAGACCGATCAGAGAGGTTACAGTTTTT
GATCCCCGCACATATTACCCAGGCACTTCAAGAGAGTGCCTGGGTAATATGTGCTTTTT
GATCCCCCTGGTCAGTTAATAGGTCCTTCAAGAGAGGACCTATTAACTGACCAGTTTTT
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USP48 ENSG00000090686
GATCCCCCACATTTCTTCAAGTGTGGTTCAAGAGACCACACTTGAAGAAATGTGTTTTT
GATCCCCCAGAATGCAACAAGAAAGATTCAAGAGATCTTTCTTGTTGCATTCTGTTTTT
GATCCCCGGCTTGTTTCTAAAGAGGCTTCAAGAGAGCCTCTTTAGAAACAAGCCTTTTT
GATCCCCGTTCGTGGTGAGAAAGCACTTCAAGAGAGTGCTTTCTCACCACGAACTTTTT
USP49 ENSG00000164663
GATCCCCGATTGGGGTCCATGTCGTCTTCAAGAGAGACGACATGGACCCCAATCTTTTT
GATCCCCGCTAGAAAGCAGTTAATGATTCAAGAGATCATTAACTGCTTTCTAGCTTTTT
GATCCCCGCTAGAAAGCAGTTAATGATTCAAGAGATCATTAACTGCTTTCTAGCTTTTT
GATCCCCCAGGACGCGCAGGAATTTCTTCAAGAGAGAAATTCCTGCGCGTCCTGTTTTT
USP54 ENSG00000166348
GATCCCCCCAGCATATTGGGACCAGATTCAAGAGATCTGGTCCCAATATGCTGGTTTTT
GATCCCCCAGCAGAAATGGAGCATGGTTCAAGAGACCATGCTCCATTTCTGCTGTTTTT
GATCCCCCTAACCTACACTGCCACACTTCAAGAGAGTGTGGCAGTGTAGGTTAGTTTTT
GATCCCCGGTTTACCTAAAGCACCAGTTCAAGAGACTGGTGCTTTAGGTAAACCTTTTT
VCIP135 ENSG00000175073
GATCCCCGCTCTGTTCCATGACTTCATTCAAGAGATGAAGTCATGGAACAGAGCTTTTT
GATCCCCCAAACCAATCTGTATTGCATTCAAGAGATGCAATACAGATTGGTTTGTTTTT
GATCCCCGCAGTAATGGATAATCGCCTTCAAGAGAGGCGATTATCCATTACTGCTTTTT
GATCCCCGCATAATACAGGGACAGACTTCAAGAGAGTCTGTCCCTGTATTATGCTTTTT
OTUD2, YOD1 ENSG00000180667
GATCCCCCCAGGCCCAGAAGTTCACCTTCAAGAGAGGTGAACTTCTGGGCCTGGTTTTT
GATCCCCCGTGGTGCTTCTAGTTACGTTCAAGAGACGTAACTAGAAGCACCACGTTTTT
GATCCCCGCGATCCAGACTTCTATAGTTCAAGAGACTATAGAAGTCTGGATCGCTTTTT
GATCCCCGCACTGGAATTAGCAGATGTTCAAGAGACATCTGCTAATTCCAGTGCTTTTT
A20 ENSG00000118503
GATCCCCCAAACTCCCAAAGCTGAACTTCAAGAGAGTTCAGCTTTGGGAGTTTGTTTTT
GATCCCCGTTTGGAATCAGGTTCCAATTCAAGAGATTGGAACCTGATTCCAAACTTTTT
GATCCCCGAAATACACATATTTGTCCTTCAAGAGAGGACAAATATGTGTATTTCTTTTT
GATCCCCGGAAACAGACACACGCAACTTCAAGAGAGTTGCGTGTGTCTGTTTCCTTTTT
BRCC36, BRCC3 ENSG00000185515
GATCCCCCTGAAATGCGCACAGTTGCTTCAAGAGAGCAACTGTGCGCATTTCAGTTTTT
GATCCCCGTGTGCCTTGAATCAGCAGTTCAAGAGACTGCTGATTCAAGGCACACTTTTT
GATCCCCGATCCATAATGGCTCAGTGTTCAAGAGACACTGAGCCATTATGGATCTTTTT
GATCCCCCCAACAGCATTTGCAGGAATTCAAGAGATTCCTGCAAATGCTGTTGGTTTTT
Cezanne-1 ENSG00000163113
GATCCCCGGGAGTTGAGAAGGAAGCGTTCAAGAGACGCTTCCTTCTCAACTCCCTTTTT
GATCCCCGAGTTTCACGTCTTTGTCCTTCAAGAGAGGACAAAGACGTGAAACTCTTTTT
GATCCCCCCCTGAAGATGGGTCACCGTTCAAGAGACGGTGACCCATCTTCAGGGTTTTT
GATCCCCGGACAAGAAGAGAGCAGATTTCAAGAGAATCTGCTCTCTTCTTGTCCTTTTT
Cezanne-2 ENSG00000169918
GATCCCCGCCCATTTCTCTGCCCTTGTTCAAGAGACAAGGGCAGAGAAATGGGCTTTTT
GATCCCCGCTGAACCTTCTGCACAGCTTCAAGAGAGCTGTGCAGAAGGTTCAGCTTTTT
GATCCCCCAATGTTAAGAGACTCAGGTTCAAGAGACCTGAGTCTCTTAACATTGTTTTT
GATCCCCCGAGCTGTAAACGGCTTCTTTCAAGAGAAGAAGCCGTTTACAGCTCGTTTTT
CSN5, JAB1, SGN5 ENSG00000121022
GATCCCCCCATGATCATTATGGACAGTTCAAGAGACTGTCCATAATGATCATGGTTTTT
GATCCCCGGATCACCATTACTTTAAGTTCAAGAGACTTAAAGTAATGGTGATCCTTTTT
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GATCCCCCCCGAGTAAATGCTCAGGCTTCAAGAGAGCCTGAGCATTTACTCGGGTTTTT
GATCCCCCTACCATAGAAGCTATCCATTCAAGAGATGGATAGCTTCTATGGTAGTTTTT
CSN6, SGN6 ENSG00000168090
GATCCCCGTTGAACCCTATGACCAAGTTCAAGAGACTTGGTCATAGGGTTCAACTTTTT
GATCCCCGATTATCATTGACAAGGAATTCAAGAGATTCCTTGTCAATGATAATCTTTTT
GATCCCCCATCTCAGACCACTGGATCTTCAAGAGAGATCCAGTGGTCTGAGATGTTTTT
GATCCCCCGCATTGGTGTAGACCACGTTCAAGAGACGTGGTCTACACCAATGCGTTTTT
DUB-3 ENSG00000182945
GATCCCCCTACATGCTGTCCCGGGAGTTCAAGAGACTCCCGGGACAGCATGTAGTTTTT
GATCCCCGCAGGAAGATGCCCATGAATTCAAGAGATTCATGGGCATCTTCCTGCTTTTT
GATCCCCGGACACCACCCTCATCCACTTCAAGAGAGTGGATGAGGGTGGTGTCCTTTTT
GATCCCCCAAGCAGGTAGATCATCACTTCAAGAGAGTGATGATCTACCTGCTTGTTTTT
eIF-epsilon ENSG00000175390
GATCCCCGTGGCTGTTGACATGGAATTTCAAGAGAATTCCATGTCAACAGCCACTTTTT
GATCCCCGCCTACGTCAGCACTTTAATTCAAGAGATTAAAGTGCTGACGTAGGCTTTTT
GATCCCCCGCATCGGAGTTGACCTGATTCAAGAGATCAGGTCAACTCCGATGCGTTTTT
GATCCCCGATGAAGTGGCTGTTGACATTCAAGAGATGTCAACAGCCACTTCATCTTTTT
eIF-3-gamma ENSG00000147677
GATCCCCGAAGGACAAGGAACTGAAGTTCAAGAGACTTCAGTTCCTTGTCCTTCTTTTT
GATCCCCGTGCAGATAGATGGCCTTGTTCAAGAGACAAGGCCATCTATCTGCACTTTTT
GATCCCCGTCCAATATCAGATGGAAATTCAAGAGATTTCCATCTGATATTGGACTTTTT
GATCCCCCTTGAAAAGAAGTCAGCTGTTCAAGAGACAGCTGACTTCTTTTCAAGTTTTT
ENSG00000197767 ENSG00000197767
GATCCCCGATTGCCAAGAATGTGCAATTCAAGAGATTGCACATTCTTGGCAATCTTTTT
GATCCCCGCTCCCTGCTAAACCTCTCTTCAAGAGAGAGAGGTTTAGCAGGGAGCTTTTT
GATCCCCGATTGCCAAGAATGTGCAATTCAAGAGATTGCACATTCTTGGCAATCTTTTT
GATCCCCGCAGGAAGATGCCCATGAATTCAAGAGATTCATGGGCATCTTCCTGCTTTTT
ENSG00000198817 ENSG00000198817
GATCCCCGCCTATGTCAGCACTTTAATTCAAGAGATTAAAGTGCTGACATAGGCTTTTT
GATCCCCGATGAAGTGGCTGTTGACATTCAAGAGATGTCAACAGCCACTTCATCTTTTT
GATCCCCCGCATCGGAGTTGAGCTGATTCAAGAGATCAGCTCAACTCCGATGCGTTTTT
GATCCCCGAGTGATTGGACTCTTAAGTTCAAGAGACTTAAGAGTCCAATCACTCTTTTT
HIN-1-like ENSG00000118976
GATCCCCCTAATCTGGAACCTAATGTTTCAAGAGAACATTAGGTTCCAGATTAGTTTTT
GATCCCCGTTGGAGACAAATGTCAAGTTCAAGAGACTTGACATTTGTCTCCAACTTTTT
GATCCCCCTGCTGTTGCTGCTGCTGATTCAAGAGATCAGCAGCAGCAACAGCAGTTTTT
GATCCCCGACAACGTGAGTTCTCTAGTTCAAGAGACTAGAGAACTCACGTTGTCTTTTT
HIN-6 ENSG00000189401
GATCCCCGACCAGCTGGTGTTCAGCGTTCAAGAGACGCTGAACACCAGCTGGTCTTTTT
GATCCCCGACCTGGCCAAGATGAATCTTCAAGAGAGATTCATCTTGGCCAGGTCTTTTT
GATCCCCCGACGACTTCATGATCTACTTCAAGAGAGTAGATCATGAAGTCGTCGTTTTT
GATCCCCGAAGCCGATCATCCTGGTCTTCAAGAGAGACCAGGATGATCGGCTTCTTTTT
IFP38 ENSG00000187684
GATCCCCGCCTATGTCAGCACTTTAATTCAAGAGATTAAAGTGCTGACATAGGCTTTTT
GATCCCCGTTTCTCCAAATGAGCTCATTCAAGAGATGAGCTCATTTGGAGAAACTTTTT
GATCCCCCGGCCATATGAGCATCAAATTCAAGAGATTTGATGCTCATATGGCCGTTTTT
GATCCCCGTGTTCACACCTTTGACAGTTCAAGAGACTGTCAAAGGTGTGAACACTTTTT
JAMM2 ENSG00000162601
GATCCCCCAGAGAATGGCCTTATTCCTTCAAGAGAGGAATAAGGCCATTCTCTGTTTTT
GATCCCCGAATTCTAGCAGTGATCTCTTCAAGAGAGAGATCACTGCTAGAATTCTTTTT
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GATCCCCCTGGTGTGATGCAAAGGACTTCAAGAGAGTCCTTTGCATCACACCAGTTTTT
GATCCCCCAGAGAATGGCCTTATTCCTTCAAGAGAGGAATAAGGCCATTCTCTGTTTTT
JAMM3 ENSG00000008382
GATCCCCGTAACATCCTTTGCAGCCATTCAAGAGATGGCTGCAAAGGATGTTACTTTTT
GATCCCCGAGGAGATCTACCAGAGCCTTCAAGAGAGGCTCTGGTAGATCTCCTCTTTTT
GATCCCCCATCGACGCACAGATGGACTTCAAGAGAGTCCATCTGTGCGTCGATGTTTTT
GATCCCCCACCCTGGTGGAAGTAACATTCAAGAGATGTTACTTCCACCAGGGTGTTTTT
JOSD1 ENSG00000100221
GATCCCCATGGCAACTACGATGTGAATTCAAGAGATTCACATCGTAGTTGCCATTTTTT
GATCCCCAGGCTATGAAGCTGTTTGGTTCAAGAGACCAAACAGCTTCATAGCCTTTTTT
GATCCCCCTCAAGATGCCCGAGTGGATTCAAGAGATCCACTCGGGCATCTTGAGTTTTT
GATCCCCACGTCTTCCAGGACAGCAATTCAAGAGATTGCTGTCCTGGAAGACGTTTTTT
JOSD2 ENSG00000161677
GATCCCCCCGGCAACTATGATGTCAATTCAAGAGATTGACATCATAGTTGCCGGTTTTT
GATCCCCCGTTCTGCAGCAGCAGCTCTTCAAGAGAGAGCTGCTGCTGCAGAACGTTTTT
GATCCCCCTATGATGTCAATGTGATCTTCAAGAGAGATCACATTGACATCATAGTTTTT
GATCCCCCCTGGACTCCAAGCTGCGGTTCAAGAGACCGCAGCTTGGAGTCCAGGTTTTT
OTUD1 ENSG00000165312
GATCCCCCTTCCGACTGAGCGAGCACTTCAAGAGAGTGCTCGCTCAGTCGGAAGTTTTT
GATCCCCGATGCCCGCCTTCTCCTCCTTCAAGAGAGGAGGAGAAGGCGGGCATCTTTTT
GATCCCCGCAGGACAAGTATCTGCGGTTCAAGAGACCGCAGATACTTGTCCTGCTTTTT
GATCCCCGCCGGTGATCGTCTCCAGGTTCAAGAGACCTGGAGACGATCACCGGCTTTTT
OTUD5 ENSG00000068308
GATCCCCCAGGAAGCGGAAAAACAATTTCAAGAGAATTGTTTTTCCGCTTCCTGTTTTT
GATCCCCTGCCGACTACTTCTCCAACTTCAAGAGAGTTGGAGAAGTAGTCGGCATTTTT
GATCCCCGGAGGATGGCGCCTGTCTCTTCAAGAGAGAGACAGGCGCCATCCTCCTTTTT
GATCCCCCAGGAATACCTAGACAGTATTCAAGAGATACTGTCTAGGTATTCCTGTTTTT
OTUD6B ENSG00000155100
GATCCCCCGGATAGCTGAAGCTGAAATTCAAGAGATTTCAGCTTCAGCTATCCGTTTTT
GATCCCCTAGAGATAATACAGGCAGATTCAAGAGATCTGCCTGTATTATCTCTATTTTT
GATCCCCCAAACCCTAATACAGGAGATTCAAGAGATCTCCTGTATTAGGGTTTGTTTTT
GATCCCCCCACTAATACTTGTATATATTCAAGAGATATATACAAGTATTAGTGGTTTTT
POH1, RPN11 ENSG00000115233
GATCCCCCAAGTCTATATCTCTTCCCTTCAAGAGAGGGAAGAGATATAGACTTGTTTTT
GATCCCCCAAGCCATCTATCCAGGCATTCAAGAGATGCCTGGATAGATGGCTTGTTTTT
GATCCCCGGCCGGAGATGGTTGTTGGTTCAAGAGACCAACAACCATCTCCGGCCTTTTT
GATCCCCCAGCTGGCAATAAAGAATGTTCAAGAGACATTCTTTATTGCCAGCTGTTTTT
PRP8 ENSG00000174231
GATCCCCGGACAACCCCAACCTGCTGTTCAAGAGACAGCAGGTTGGGGTTGTCCTTTTT
GATCCCCCCAGATTCCCAATCGTAGATTCAAGAGATCTACGATTGGGAATCTGGTTTTT
GATCCCCGATGTATGAGAAGATCGACTTCAAGAGAGTCGATCTTCTCATACATCTTTTT
GATCCCCGATTCATGGGATCGTGGCATTCAAGAGATGCCACGATCCCATGAATCTTTTT
STAMBP, AMSH ENSG00000124356
GATCCCCGAAGAAGGAAGCAGAGGAATTCAAGAGATTCCTCTGCTTCCTTCTTCTTTTT
GATCCCCCAGTCTCATCCATACAGCCTTCAAGAGAGGCTGTATGGATGAGACTGTTTTT
GATCCCCGTTCCAGGAAACTGGATTCTTCAAGAGAGAATCCAGTTTCCTGGAACTTTTT
GATCCCCGGCAGAGCTGTTAAAACGATTCAAGAGATCGTTTTAACAGCTCTGCCTTTTT
AMSH-like ENSG00000138134
GATCCCCCTCATGTTGCCAGAGGCCATTCAAGAGATGGCCTCTGGCAACATGAGTTTTT
GATCCCCGAAACTGAAGGAGATTGCATTCAAGAGATGCAATCTCCTTCAGTTTCTTTTT
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Figure S1 shRNAs affecting eIF3f level inhibit transla-
tion. U2OS cells were transfected with DE-encoding vector
together with three increasing doses of sh eIF3f P1. After 24 h,
immunostaining was performed with anti-myc antibody, and
nuclei were stained with Hoechst. The images were acquired using
an Axio Imager microscope with a 206 magnification objective.
The percentage of myc-positive cells was calculated in each case
after counting 163, 226, 155, and 214 cells, respectively. This
representative of several experiments shows that eIF3f inhibition
affects the translation efficiency of DE-encoding vector. The same
type of result was obtained with all isolated shRNAs targeting
eIF3f at different doses. Note also that at the lower dose (Dose 1 in
the second lane), the subcellular localization of myc staining was
affected compared to DE alone (first lane), Notch being partially
retained in extra-nuclear structures.
Found at: doi:10.1371/journal.pbio.1000545.s001 (0.36 MB
DOC)
Figure S2 sh eIF3f #3 does not affect Ndfip2 ubiquiti-
nation. U2OS cells were transfected with vectors encoding GFP-
tagged Ndfip2 and 6xHis-tagged Ubiquitin. We added shRNA #3
in the presence or not of the murine shRNA #3 insensitive
meIF3f. Proteins were extracted in denaturing conditions and
ubiquitinated products were purified on Nickel-charged beads.
Whole cell extracts (WCE) and ubiquitinated products (Nickel)
were analyzed by Western blot using the anti-GFP antibody to
quantify the levels of ubiquitinated Ndfip2. These data suggest that
neither sh eIF3f #3 nor meIF3f overexpression has an effect on
Ndfip2 ubiquitination.
Found at: doi:10.1371/journal.pbio.1000545.s002 (0.96 MB PPT)
Figure S3 eIF3f does interact with DTX but not with
Itch/AIP4. HEK-293T cells were transfected with vectors
encoding HA-tagged meIF3f and VSV-tagged DTX or Flag-
tagged Itch/AIP4. 24 h after trasnsfection, cells were lysed and
proteins were extracted. meIF3f was immunoprecipitated using
anti-HA antibody. Finally, whole cell extracts (WCE) and
immunoprecipitates were analyzed by Western blot using the
indicated antibodies. These data show that DTX is co-immuno-
precipitated with eIF3f (Lane B), whereas Itch/AIP4 is not (Lane
C).
Found at: doi:10.1371/journal.pbio.1000545.s003 (0.99 MB PPT)
Figure S4 A chimera between ubiquitin and Notch IC is
partially located outside of the nucleus and presents a
transcriptional activity defect. (A) U2OS cells were trans-
fected with vectors encoding NIC (first lane), NIC(KR), where the
Lysine 1749 of murine Notch1 was mutated to Arginine [8], or
UBIC (obtained by inserting a PCR-amplified NIC(KR) at the
AgeI site of UbG76V, K29/48R-GFP [28], therefore NIC being
in frame 39 to the ubiquitin sequence and the GFP being off-
frame). After 24 h, immunostaining was performed with rabbit
anti-Notch-IC antibody [57]. Nuclei were stained with Hoechst.
The percentage of cells presenting extra-nuclear staining was
calculated after counting more than 100 random transfected cells
on three independent experiments. It was 4% for both NIC and
NIC(KR) on average, and 18% for UBIC. These data suggest that
monoubiquitination is sufficient to partially hinder NIC nuclear
import. (B) U2OS cells were transfected with increasing doses of
NIC (A to C), NIC(KR) (D to F), or UBIC (G to I) together with a
CSL-Luciferase reporter and a pRL-TK vector encoding Renilla
luciferase used as an internal control. After 24 h, relative luciferase
activity was measured and cell extracts were analyzed by Western
blot. CSL activation was repressed in a dose-dependent manner
with UBIC, respectively, reaching 66%, 79%, and 80% of
reduction compared to the similar doses of NIC.
Found at: doi:10.1371/journal.pbio.1000545.s004 (4.97 MB PPT)
Figure S5 shRNAs targeting eIF3f have no effect on NIC-
mediated transcriptional activation. U2OS cells were
transfected with vectors encoding CSL-firefly luciferase (Notch
reporter) and TK-renilla luciferase (internal control reporter),
together with NIC (Lane A) and increasing doses of eIF3f shRNA
P2 (B–D), shRNA #1 (E–G), or a control pool targeting AMSH
(H–J). 24 h after transfection, relative luciferase activity was
measured and cell extracts were analyzed by Western blot. These
data show that NIC-mediated CSL activation is not affected by
shRNAs targeting eIF3f. This suggests that CSL-activation
decrease observed in coculture experiments in the presence of
eIF3f shRNAs is not due to an effect of these shRNAs on Notch-
associated transcription factors.
Found at: doi:10.1371/journal.pbio.1000545.s005 (0.54 MB PPT)
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DUB Enzyme (Putative)/Sense Oligo Sequences Ensembl Gene ID
GATCCCCCAATTCCTTGCTGAATGTATTCAAGAGATACATTCAGCAAGGAATTGTTTTT
GATCCCCGCATAAAGACACTGGCATCTTCAAGAGAGATGCCAGTGTCTTTATGCTTTTT
TL132-like ENSG00000189423
GATCCCCGACACTCATATTAAGCCTATTCAAGAGATAGGCTTAATATGAGTGTCTTTTT
GATCCCCCCCAAACTGCAAGTGGTACTTCAAGAGAGTACCACTTGCAGTTTGGGTTTTT
GATCCCCGATGGCAGACACAAGCAGGTTCAAGAGACCTGCTTGTGTCTGCCATCTTTTT
GATCCCCGTGAAGAAGACAGCACTGATTCAAGAGATCAGTGCTGTCTTCTTCACTTTTT
doi:10.1371/journal.pbio.1000545.t001
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